These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35014175)

  • 61. Different effects of enoxaparin and unfractionated heparin on some thrombogenesis markers during hemodialysis: a cross-over study.
    Naumnik B; Pawlak K; Myśliwiec M
    Thromb Res; 2009 Feb; 123(4):631-6. PubMed ID: 18234290
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Reprocessing high-flux polysulfone dialyzers does not negatively impact solute removal in short-daily online hemodiafiltration.
    Melo NC; Moyses RM; Elias RM; Castro MC
    Hemodial Int; 2014 Apr; 18(2):473-80. PubMed ID: 24393428
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Use of single dose low-molecular-weight heparin in long hemodialysis.
    Lai KN; Ho K; Li M; Szeto CC
    Int J Artif Organs; 1998 Apr; 21(4):196-200. PubMed ID: 9649059
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A low molecular weight heparin ("fragmin") for routine hemodialysis: a crossover trial comparing three dose regimens with a standard regimen of commercial unfractionated heparin.
    Anastassiades E; Lane DA; Ireland H; Flynn A; Curtis JR
    Clin Nephrol; 1989 Dec; 32(6):290-6. PubMed ID: 2558829
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Comparative Effectiveness between Expanded Hemodialysis (Hemodialysis Using a Medium Cut-Off Dialyzer) and Mixed-Dilution Online Hemodiafiltration Using a High-Flux Dialyzer in Removing Middle-Molecule Uremic Toxins.
    Eiamcharoenying J; Takkavatakarn K; Chariyavilaskul P; Susantitaphong P; Eiam-Ong S; Tiranathanagul K
    Blood Purif; 2022; 51(11):923-931. PubMed ID: 35279655
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The effect of oral anticoagulation on clotting during hemodialysis.
    Ziai F; Benesch T; Kodras K; Neumann I; Dimopoulos-Xicki L; Haas M
    Kidney Int; 2005 Aug; 68(2):862-6. PubMed ID: 16014067
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Improvement of clinical outcomes in dialysis: No convincing superiority in dialysis efficacy using hemodiafiltration vs high-flux hemodialysis.
    Abdelsalam M; Demerdash TM; Assem M; Awais M; Shaheen M; Sabri A; Alanany H; Kashgary A; Alsuwaida A
    Ther Apher Dial; 2021 Aug; 25(4):483-489. PubMed ID: 32243070
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Hemodialysis without anticoagulation: Less clotting in conventional hemodialysis than in predilution hemodiafiltration.
    Krummel T; Cellot E; Thiery A; De Geyer G; Keller N; Hannedouche T
    Hemodial Int; 2019 Oct; 23(4):426-432. PubMed ID: 31380605
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Venographic comparison of subcutaneous low-molecular weight heparin with oral anticoagulant therapy in the long-term treatment of deep venous thrombosis.
    Gonzalez-Fajardo JA; Arreba E; Castrodeza J; Perez JL; Fernandez L; Agundez I; Mateo AM; Carrera S; Gutiérrez V; Vaquero C
    J Vasc Surg; 1999 Aug; 30(2):283-92. PubMed ID: 10436448
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Dalteparin dosing in high-flux haemodialysis and haemodiafiltration.
    Sridharan S; Berdeprado J; Sivalingam M; Farrington K
    Nephron Clin Pract; 2012; 122(1-2):53-7. PubMed ID: 23548465
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Detection and Scoring of Extracorporeal Circuit Clotting During Hemodialysis.
    Vanommeslaeghe F; Van Biesen W; François K
    Semin Nephrol; 2023 Nov; 43(6):151474. PubMed ID: 38267348
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Citrate compared to low molecular weight heparin anticoagulation in chronic hemodialysis patients.
    Janssen MJ; Deegens JK; Kapinga TH; Beukhof JR; Huijgens PC; van Loenen AC; van der Meulen J
    Kidney Int; 1996 Mar; 49(3):806-13. PubMed ID: 8648924
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Enoxaparin versus unfractioned heparin as anticoagulant for continuous venovenous hemodialysis: a randomized open-label trial.
    Garcés EO; Victorino JA; Thomé FS; Röhsig LM; Dornelles E; Louzada M; Stifft J; de Holanda F; Veronese FV
    Ren Fail; 2010 Jan; 32(3):320-7. PubMed ID: 20370447
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Efficacy and Safety of the Medium Cut-Off Elisio HX Dialyzer.
    Maduell F; Broseta JJ; Rodríguez-Espinosa D; Del Risco-Zevallos J; Gómez M; Rodas LM; Arias-Guillén M; Vera M; Fontseré N; Salgado MDC; Rico N
    Blood Purif; 2023; 52(1):68-74. PubMed ID: 35551384
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Anti-metastatic effect of a non-anticoagulant low-molecular-weight heparin versus the standard low-molecular-weight heparin, enoxaparin.
    Mousa SA; Linhardt R; Francis JL; Amirkhosravi A
    Thromb Haemost; 2006 Dec; 96(6):816-21. PubMed ID: 17139378
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effects of Hemodialysis Therapy Using Dialyzers with Medium Cut-Off Membranes on Middle Molecules.
    Kirsch AH; Rosenkranz AR; Lyko R; Krieter DH
    Contrib Nephrol; 2017; 191():158-167. PubMed ID: 28910799
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Use of enoxaparin to diminish the incidence of vascular access stenosis/thrombosis in chronic hemodialysis patients.
    Shavit L; Lifschitz M; Lee S; Slotki I
    Int Urol Nephrol; 2011 Jun; 43(2):499-505. PubMed ID: 20063059
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Low molecular weight heparins as thromboprophylaxis in patients undergoing hemodialysis/hemofiltration or continuous renal replacement therapies.
    Sagedal S; Hartmann A
    Eur J Med Res; 2004 Mar; 9(3):125-30. PubMed ID: 15096322
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Acute Effects of Hemodiafiltration Versus Conventional Hemodialysis on Endothelial Function and Inflammation: A Randomized Crossover Study.
    Jia P; Jin W; Teng J; Zhang H; Zou J; Liu Z; Shen B; Cao X; Ding X
    Medicine (Baltimore); 2016 Apr; 95(16):e3440. PubMed ID: 27100440
    [TBL] [Abstract][Full Text] [Related]  

  • 80. High-Flux Dialysis: Clinical, Biochemical, and Proteomic Comparison with Low-Flux Dialysis and On-Line Hemodiafiltration.
    Donadio C; Kanaki A; Sami N; Tognotti D
    Blood Purif; 2017; 44(2):129-139. PubMed ID: 28571019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.